Kanish Mirchia

1.1k citations
46 papers · 483 indexed · h-index 12
Topics
Glioma Diagnosis and Treatment (14 papers)Meningioma and schwannoma management (8 papers)Chromatin Remodeling and Cancer (5 papers)

In The Last Decade

Kanish Mirchia

40 papers receiving 478 citations

Peers

Kanish Mirchia
Comparison fields: 5 of 70
  • Genetics 167
  • Radiology, Nuclear Medicine and Imaging 127
  • Molecular Biology 120
  • Ophthalmology 80
  • Cancer Research 78
Replace Hirotomo Tanaka with:
Hirotomo Tanaka Japan
Michele M. Bloomer United States
Ruichong Ma United Kingdom
Samer E. Kaba United States
Christina Stathopoulos Switzerland
Benjamin Liechty United States
Fehim Esen Türkiye
Seiji Kannuki Japan
Michael Karremann Germany
Manoj Parulekar United Kingdom
Kanish Mirchia relative to Hirotomo Tanaka Japan Hirotomo Tanaka's profile →
Citations per field
00.5×5.3×
Hirotomo Tanaka · 1×
Citations per year

Countries citing papers authored by Kanish Mirchia

Since Specialization
Citations

This map shows the geographic impact of Kanish Mirchia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kanish Mirchia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kanish Mirchia more than expected).

Fields of papers citing papers by Kanish Mirchia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kanish Mirchia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kanish Mirchia. The network helps show where Kanish Mirchia may publish in the future.

Co-authorship network of co-authors of Kanish Mirchia

This figure shows the co-authorship network connecting the top 25 collaborators of Kanish Mirchia. A scholar is included among the top collaborators of Kanish Mirchia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kanish Mirchia. Kanish Mirchia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 1
3 15
4 2
5 11
6 2
7 3
8 10
9 3
10 3
11 1
12 1
13 2
14 1
15 1
16 54
17 53
18 19
19 3
20 91

About Kanish Mirchia

Kanish Mirchia is a scholar working on Genetics, Ophthalmology and Neurology, having authored 46 papers that have together received 483 indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (14 papers), Meningioma and schwannoma management (8 papers) and Chromatin Remodeling and Cancer (5 papers). The work is most often cited by research in Genetics (167 citations), Ophthalmology (80 citations) and Neurology (56 citations). Kanish Mirchia has collaborated with scholars based in United States, Slovakia and India. Frequent co-authors include Timothy E. Richardson, Ashok Sharma, Verinder S. Nirankari, Charles L. Howe, Kanwar Mohan, Rajan Sharma, Reghann G. LaFrance‐Corey, Matija Snuderl, Jamie M. Walker and Emma N. Goddery. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Nature Genetics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026